Skip to main content

Table 1 The characteristics of included studies for this meta-analysis

From: CTLA-4 polymorphisms and predisposition to digestive system malignancies: a meta-analysis of 31 published studies

First author, year

Country

Ethnicity

Type of disease

Sample size

Genotypes (wtwt/wtmt/mtmt)

P value for HWE

NOS score

Cases

Controls

rs231775 A/G

 Cai 2011*

China

East Asian

Esophageal cancer

125/250

30/68/27

70/133/47

0.248

8

 Cheng 2006*

Taiwan

East Asian

Gastric cancer

62/250

34/26/2

119/102/29

0.323

7

 Cheng 2011*

China

East Asian

Esophageal cancer

205/205

54/105/46

90/79/36

0.013

7

 Cozar 2007*

Spain

Caucasian

Colorectal cancer

96/176

46/44/6

78/77/21

0.766

8

 Cui 2012*

China

East Asian

Colorectal cancer

128/205

73/46/9

84/68/53

< 0.001

7

 Cui 2016*

China

East Asian

Liver cancer

96/205

52/37/7

64/96/45

0.429

7

 Dilmec 2008*

Turkey

Mixed

Colorectal cancer

56/162

36/19/1

108/43/11

0.028

7

 Fan 2012*

China

East Asian

Colorectal cancer

291/352

123/146/22

170/138/44

0.059

8

 Ge 2015*

China

East Asian

Colorectal cancer

572/626

296/242/34

292/284/50

0.094

7

 Gu 2010*

China

East Asian

Liver cancer

367/407

150/166/51

183/179/45

0.902

8

 Hadinia 2007*

Iran

Mixed

Colorectal cancer

105/190

52/47/6

117/59/14

0.097

8

 Hadinia 2007*

Iran

Mixed

Gastric cancer

46/190

27/13/6

117/59/14

0.097

8

 Hou 2010*

China

East Asian

Gastric cancer

205/262

94/70/41

107/100/55

< 0.001

7

 Hu 2010*

China

East Asian

Liver cancer

853/854

367/380/106

399/376/79

0.476

8

 Lang 2012*

China

East Asian

Pancreatic cancer

602/651

208/312/82

263/326/62

0.006

8

 Li 2011*

China

East Asian

Colorectal cancer

248/380

120/120/8

171/167/42

0.898

8

 Liu 2015*

China

East Asian

Liver cancer

80/78

29/36/15

38/33/7

0.966

7

 Liu 2015*

China

East Asian

Esophageal cancer

629/686

307/254/43

310/296/58

0.284

7

 Liu 2019*

China

East Asian

Gastric cancer

487/1470

228/215/44

698/631/141

0.926

7

 Mahajan 2008*

Poland

Caucasian

Gastric cancer

301/411

89/153/59

152/189/70

0.393

7

 Qi 2010*

China

East Asian

Colorectal cancer

124/407

60/60/4

183/179/45

0.902

8

 Solerio 2005*

Italy

Caucasian

Colorectal cancer

132/238

76/43/13

128/91/19

0.618

8

 Sun 2008*

China

East Asian

Gastric cancer

530/530

235/235/60

282/209/39

0.974

8

 Sun 2008*

China

East Asian

Esophageal cancer

629/686

307/254/43

310/290/58

0.398

8

 Tang 2016*

China

East Asian

Gastric cancer

330/590

155/153/22

278/264/48

0.179

8

 Wang 2015*

China

East Asian

Colorectal cancer

311/389

121/147/43

141/147/101

< 0.001

7

 Yang 2012*

China

East Asian

Pancreatic cancer

368/926

140/178/50

482/374/70

0.828

8

 Yang 2015*

China

East Asian

Colorectal cancer

240/147

195/39/6

102/40/5

0.662

7

 Yang 2019*

China

East Asian

Liver cancer

575/920

290/221/64

444/389/87

0.893

8

 Yuan 2012*

China

East Asian

Gastric cancer

118/96

65/45/8

30/45/21

0.595

7

 Zou 2018*

China

East Asian

Colorectal cancer

979/1299

417/443/119

621/563/115

0.430

8

rs4553808 A/G

 Cui 2016*

China

East Asian

Liver cancer

96/205

33/56/7

79/96/30

0.924

7

 Hadinia 2007*

Iran

Mixed

Colorectal cancer

109/188

74/33/2

145/36/7

0.02

7

 Hadinia 2007*

Iran

Mixed

Gastric cancer

46/188

37/9/0

145/36/7

0.02

7

 Hou 2010*

China

East Asian

Gastric cancer

205/262

112/71/22

163/54/45

< 0.001

7

rs5742909 C/T

 Cheng 2006*

Taiwan

East Asian

Gastric cancer

62/250

59/3/0

209/40/1

0.323

7

 Dilmec 2008*

Turkey

Mixed

Colorectal cancer

56/162

48/8/0

149/12/1

0.185

7

 Hadinia 2007*

Iran

Mixed

Gastric cancer

46/187

38/8/0

159/24/4

0.014

8

 Hadinia 2007*

Iran

Mixed

Colorectal cancer

108/187

91/16/1

159/24/4

0.013

7

 Li 2009*

China

East Asian

Gastric cancer

236/121

206/27/3

99/17/5

0.001

7

 Wang 2019*

China

East Asian

Liver cancer

554/612

360/170/24

466/134/12

0.517

8

 Yang 2015*

China

East Asian

Colorectal cancer

240/147

150/82/8

94/48/5

0.707

7

rs3087243 CT60AG

 Cheng 2006*

Taiwan

East Asian

Gastric cancer

62/250

39/20/3

154/79/17

0.126

7

 Cozar 2007*

Spain

Caucasian

Colorectal cancer

95/175

20/56/19

40/88/47

0.923

7

 Ge 2015*

China

East Asian

Colorectal cancer

1699/627

1258/425/16

413/198/16

0.174

8

 Liu 2019*

China

East Asian

Gastric cancer

487/1472

302/172/13

958/462/52

0.686

8

 Tang 2016*

China

East Asian

Gastric cancer

316/580

213/98/5

382/182/16

0.302

8

 Wang 2019*

China

East Asian

Liver cancer

554/612

200/238/116

240/274/98

0.185

8

 Yang 2019*

China

East Asian

Liver cancer

575/921

325/221/29

609/282/30

0.703

8

 Zou 2018*

China

East Asian

Colorectal cancer

980/1300

637/296/47

850/408/42

0.410

8

rs733618 T/C

 Cui 2016*

China

East Asian

Liver cancer

96/205

72/24/0

181/24/0

0.373

7

 Hadinia 2007*

Iran

Mixed

Colorectal cancer

109/189

97/12/0

165/24/0

0.351

7

 Hadinia 2007*

Iran

Mixed

Gastric cancer

83/189

42/41/0

165/24/0

0.351

7

 Hou 2010*

China

East Asian

Gastric cancer

205/262

75/111/19

93/139/30

0.041

7

 Liu 2019*

China

East Asian

Gastric cancer

487/1472

168/242/77

525/685/262

0.139

8

 Tang 2014*

China

East Asian

Esophageal cancer

611/657

210/300/101

228/314/115

0.700

8

 Tang 2016*

China

East Asian

Gastric cancer

320/586

102/163/55

198/282/106

0.749

8

 Yang 2019*

China

East Asian

Liver cancer

575/921

217/268/90

320/432/169

0.275

8

 Zou 2018*

China

East Asian

Colorectal cancer

980/1300

346/464/170

458/613/229

0.335

8

rs16840252 C/T

 Liu 2019*

China

East Asian

Gastric cancer

492/1472

381/94/7

1130/329/13

0.039

8

 Tang 2016*

China

East Asian

Gastric cancer

317/603

235/78/4

460/130/13

0.293

8

 Yang 2019*

China

East Asian

Liver cancer

575/921

477/93/5

707/205/9

0.164

8

 Zou 2018*

China

East Asian

Colorectal cancer

980/1300

742/223/15

1006/283/11

0.065

8

  1. Abbreviations: wt wild type, mt mutant type, HWE Hardy-Weinberg equilibrium, NOS Newcastle-Ottawa scale, NA not available
  2. *Full manuscript of all eligible studies can be accessed at https://osf.io